Tumor-shrinking effects of enfortumab vedotin between primary urothelial carcinoma and metastatic organs., Ikarashi Daiki;Kawamura Tatsuya;Ogasawara Keita;Arakawa Yumeka;Machida Arisa;Ito Ayato;Shiomi Ei;Maekawa Shigekatsu;Kato Renpei;Kanehira Mitsugu;Sugimura Jun;Obara Wataru, Frontiers in oncology, 14, 1493922, 2025年01月29日